Sol-Gel Technologies (SLGL) Other Non-Current Assets (2018 - 2025)
Sol-Gel Technologies' (SLGL) quarterly Other Non-Current Assets came in at $62000.0 in Q4 2025, up 376.92% year-on-year from $13000.0 in Q4 2024, and down 94.76% on a QoQ basis from $1.2 million in Q2 2025.
Sol-Gel Technologies (SLGL) Other Non-Current Assets (2018 - 2025) Analysis & Trends
Sol-Gel Technologies (SLGL) has 8 years of Other Non-Current Assets data on file, last reported at $62000.0 in Q4 2025.
- On a quarterly basis, Other Non-Current Assets rose 376.92% year-over-year to $62000.0 in Q4 2025; TTM through Dec 2025 was $62000.0, a 376.92% increase from a year earlier, with the FY2025 full-year figure at $62000.0, up 376.92% from the prior year.
- Other Non-Current Assets for Q4 2025 stood at $62000.0, down from $1.2 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for SLGL reached as high as $1.5 million in Q3 2024 and fell as low as $13000.0 in Q4 2024.
- Historically, Other Non-Current Assets has averaged $739444.4 across 5 years, with a median of $1.2 million in 2021.
- Across the five-year window, Other Non-Current Assets plunged 96.29% in 2024 and soared 376.92% in 2025, its largest moves.
- Year by year, Other Non-Current Assets stood at $1.2 million in 2021, then changed by 0.0% to $1.2 million in 2022, then tumbled by 69.57% to $350000.0 in 2023, then plunged by 96.29% to $13000.0 in 2024, then surged by 376.92% to $62000.0 in 2025.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $62000.0 in Q4 2025, $1.2 million in Q2 2025, and $13000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Sol-Gel Technologies | 227.58 Mn | 217.44 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 62,000.00 |
| Jun 30, 2025 | 1.18 Mn |
| Dec 31, 2024 | 13,000.00 |
| Sep 30, 2024 | 1.54 Mn |
| Jun 30, 2024 | 1.16 Mn |
| Mar 31, 2024 | 45,000.00 |
| Dec 31, 2023 | 350,000.00 |
| Dec 31, 2022 | 1.15 Mn |
| Dec 31, 2021 | 1.15 Mn |
| Dec 31, 2020 | 1.15 Mn |
| Dec 31, 2019 | 350,000.00 |
| Dec 31, 2018 | 350,000.00 |